Moderna said on Tuesday it has begun a Phase 1 clinical trial of an Ebola vaccine set to target the Bundibugyo strain, which is currently circulating in the eastern DRC.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of…

Results may be months away, but efforts are advancing towards enhanced treatment and the world’s first vaccine for the Bundibugyo species of Ebola, the World Health Organization…